Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Uberla

Showing results (101-110 of 114) with videos related to

Pageof 12
Sort By:
Journal of Virology|March 1, 1997
Construction, replication, and immunogenic properties of a simian immunodeficiency virus expressing interleukin-2B R Gundlach, H Linhart, U Dittmer, et al.
Journal of Virology|January 22, 2000
Antiretroviral therapy during primary immunodeficiency virus infection can induce persistent suppression of virus load and protection from heterologous challenge in rhesus macaquesB Rosenwirth, P ten Haaft, W M Bogers, et al.
Neuropathology and Applied Neurobiology|June 19, 2007
The central nervous system in mucosal vaccination of rhesus macaques with simian immunodeficiency virus DeltanefG Georgsson, C Stahl-Hennig, K Tenner-Racz, et al.
Klinische Wochenschrift|October 15, 1986
Haemostasiological parameters as risk factor for new arterial occlusions in diabeticsH K Breddin, H J Krzywanek, P Althoff, et al.
International Angiology : a Journal of the International Union of Angiology|July 1, 1986
Spontaneous platelet aggregation and coagulation parameters as risk factors for arterial occlusions in diabetics. Results of the PARD-studyH K Breddin, H J Krzywanek, P Althoff, et al.
Health Policy (Amsterdam, Netherlands)|February 8, 1991
Hospital comparisons using a Euro Health Data Base for resource management and strategic planningF H France, A Alban, B Barber, et al.
AIDS Research and Human Retroviruses|May 1, 1997
Live attenuated SIV vaccines are not effective in a postexposure vaccination modelH Linhart, B R Gundlach, S Sopper, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 29, 1995
Animal model for the therapy of acquired immunodeficiency syndrome with reverse transcriptase inhibitorsK Uberla, C Stahl-Hennig, D Böttiger, et al.
Journal of Virology|June 14, 2000
Suppression of acute viremia by short-term postexposure prophylaxis of simian/human immunodeficiency virus SHIV-RT-infected monkeys with a novel reverse transcriptase inhibitor (GW420867) allows for development of potent antiviral immune responses resulting in efficient containment of infectionK Mori, Y Yasutomi, S Sawada, et al.
Arzneimittel-Forschung|January 1, 1980
[Drug monitoring in psychiatry (author's transl)]E Rüther, O Benkert, F Eckmann, et al.
Pageof 12

Showing results (101-110 of 114) with videos related to

Sort By:
Pageof 12
Journal of Virology|March 1, 1997
Construction, replication, and immunogenic properties of a simian immunodeficiency virus expressing interleukin-2B R Gundlach, H Linhart, U Dittmer, et al.
Journal of Virology|January 22, 2000
Antiretroviral therapy during primary immunodeficiency virus infection can induce persistent suppression of virus load and protection from heterologous challenge in rhesus macaquesB Rosenwirth, P ten Haaft, W M Bogers, et al.
Neuropathology and Applied Neurobiology|June 19, 2007
The central nervous system in mucosal vaccination of rhesus macaques with simian immunodeficiency virus DeltanefG Georgsson, C Stahl-Hennig, K Tenner-Racz, et al.
Klinische Wochenschrift|October 15, 1986
Haemostasiological parameters as risk factor for new arterial occlusions in diabeticsH K Breddin, H J Krzywanek, P Althoff, et al.
International Angiology : a Journal of the International Union of Angiology|July 1, 1986
Spontaneous platelet aggregation and coagulation parameters as risk factors for arterial occlusions in diabetics. Results of the PARD-studyH K Breddin, H J Krzywanek, P Althoff, et al.
Health Policy (Amsterdam, Netherlands)|February 8, 1991
Hospital comparisons using a Euro Health Data Base for resource management and strategic planningF H France, A Alban, B Barber, et al.
AIDS Research and Human Retroviruses|May 1, 1997
Live attenuated SIV vaccines are not effective in a postexposure vaccination modelH Linhart, B R Gundlach, S Sopper, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 29, 1995
Animal model for the therapy of acquired immunodeficiency syndrome with reverse transcriptase inhibitorsK Uberla, C Stahl-Hennig, D Böttiger, et al.
Journal of Virology|June 14, 2000
Suppression of acute viremia by short-term postexposure prophylaxis of simian/human immunodeficiency virus SHIV-RT-infected monkeys with a novel reverse transcriptase inhibitor (GW420867) allows for development of potent antiviral immune responses resulting in efficient containment of infectionK Mori, Y Yasutomi, S Sawada, et al.
Arzneimittel-Forschung|January 1, 1980
[Drug monitoring in psychiatry (author's transl)]E Rüther, O Benkert, F Eckmann, et al.
Pageof 12